Status:
COMPLETED
EGO-COMBO Clinical End-point Extension Study Beyond 36 Months
Lead Sponsor:
The University of Hong Kong
Conditions:
Coronary Restenosis
Eligibility:
All Genders
18+ years
Brief Summary
In this study, the safety and efficacy of COMBO TM stent beyond 36 months are assessed, in particular the occurrence of late stent thrombosis and late loss catch-up (restenosis).
Detailed Description
The Genous Stent (the EPC Capture R-stent, OrbusNeich Medical Inc., Fort Lauderdale, FL) is commercially available and has been used extensively in standard coronary intervention in the treatment of m...
Eligibility Criteria
Inclusion
- Patient previously participated in EGO-COMBO Pilot Study (UW 10-342)
Exclusion
- Patient not previously participated in EGO-COMBO Pilot Study (UW 10-342)
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT02263313
Start Date
September 1 2014
End Date
September 1 2014
Last Update
October 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine, Queen Mary Hospital, The University of Hong Kong
Hong Kong, Hong Kong, China